July 29, 2013 PXE News

July 29, 2013
Update on Gene Patenting in the USA
PXE International stewards the ABCC6 gene patent. What will change as a result of the Myriad ruling?
In June 2013, the Supreme Court of the United States (SCOTUS) passed down this ruling in the case of Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al.: "We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but that cDNA is patent eligible because it is not naturally occurring."

If this information was helpful to you, please consider making a quick donation today because every penny counts. 100% of donations go to support and research.